Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Four-amino acid part makes enzyme sensitive to finasteride.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

ALKBH5 helps wounds heal faster by stabilizing PELI2 mRNA.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

CXCR2 in skin cells promotes tumor growth.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Smad2/3-dependent TGF-β signaling increases during wound healing.

Activating β-catenin increases melanocytes and decreases Schwann cells.

Sry may regulate fatty acid metabolism and shows different expression levels in rat tissues.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

Mouse high-glycine/tyrosine proteins have distinct patterns in hair follicles, peaking at specific hair cycle days.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.